U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases Guidance for Industry December 2011

Final
Docket Number:
FDA-2011-D-0855
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research

In this guidance, we, FDA (or the Agency), provide information to assist sponsors in developing vaccines to protect against global infectious diseases. The guidance will focus on development and licensure of vaccines targeted against infectious diseases or conditions endemic in areas outside the United States (U.S.). In addition, the guidance will clarify regulations, statutes and guidances applicable to the development of these products.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2011-D-0855.

Questions?

Contact Point
Office of Communication, Outreach and Development (OCOD)
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3128
Silver Spring, MD 20993-0002
ocod@fda.hhs.gov
(800) 835-4709
(240) 402-8010